The clinical-stage biotech company is based in Sacramento, and is putting its drug candidate through medical trials.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

This merged Peninsula biotech will have about $700 million to push three clinical trials — and potentially another drug — ...

CRISPR Therapeutics partnered with big biotech Vertex Pharmaceuticals ( VRTX 3.40%) on Casgevy. Although Vertex takes a ...

More than $13 million in incentives from North Carolina are pledged to a biotech company making a $700 million investment, a ...

Amid a shaky macroeconomic backdrop, biotech stocks have underperformed, with XBI showing poor technical momentum and ...

A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which ...

Fortress Biotech, Inc. (Nasdaq: FBIO) ("Fortress”), an innovative biopharmaceutical company focused on acquiring and ...

BAY HARBOR ISLAND, Fla. (AP) — BAY HARBOR ISLAND, Fla. (AP) — Fortress Biotech Inc. (FBIO) on Thursday reported a loss of $10.6 million in its first quarter. On a per-share basis, the Bay Harbor ...

Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...

Israeli artificial intelligence biotech startup SpotitEarly Ltd. today officially launched in the U.S. and announced that it ...